Comparison of allogeneic vs autologous bone marrowâ€“derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
JAMA., Dec;308(22):2369-79 (2012)
Percutaneous mechanical thrombectomy of left atrial appendage thrombus with bilateral neuro-embolic protection followed by closure of left atrial appendage.
EuroIntervention., Jul;8(3):408-9 (2012)
Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling.
Circ. Res., Apr;108(7):792-6 (2011)
Effect of granulocyte-colony stimulating factor on systolic function of oncology patients.
J. Am. Coll. Cardiol., Jan;57(4):516-7 (2011)
Cell therapy for heart disease: where are we in 2011?
J. Am. Coll. Cardiol., Jan;57(4):466-8 (2011)
Takotsubo cardiomyopathy: utility of cardiac computed tomography angiography for acute diagnosis.
J Thorac Imaging., Aug;26(3):W83-5 (2011)
Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.
Circ. Res., Oct;107(7):913-22 (2010)
Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.
Proc. Natl. Acad. Sci. U.S.A., Aug;106(33):14022-7 (2009)
Evaluation of comorbidity scores to predict all-cause mortality in patients with established coronary artery disease.
Int. J. Cardiol., Apr;117(1):97-102 (2007)
Is TEE useful in patients with small subcortical strokes?
Eur. J. Neurol., May;13(5):522-7 (2006)
Ability of serum to decrease cellular acylCoA:cholesterol acyl transferase activity predicts cardiovascular outcomes.
Circulation., Oct;112(16):2446-53 (2005)
Relation between ascending aortic pressures and outcomes in patients with angiographically demonstrated coronary artery disease.
Am. J. Cardiol., Sep;96(5):645-8 (2005)
Correlation between apoptotic endothelial microparticles and serum interleukin-6 and C-reactive protein in healthy men.
Am. J. Cardiol., May;95(10):1258-60 (2005)
Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism.
J. Am. Coll. Cardiol., May;45(9):1467-71 (2005)
Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease.
Hypertension., May;45(5):980-5 (2005)
Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy.
Am. J. Cardiol., Jan;95(1):88-90 (2005)
Body mass index is not a risk factor for unstable angina and myocardial infarction in veteran patients with angiographically confirmed coronary artery disease.
Circulation., May;109(18):e215-6; author reply e215-6 (2004)